Add BrightSurf on Google Email

University of California - Los Angeles Health Sciences


Machine-learning technique identifies people who would benefit most from treatment to reduce future cardiovascular disease risk

Researchers used a novel machine-learning technique called causal forest, which found that treating individuals with high estimated benefits provided better population health outcomes than the traditional high-risk approach. This approach targets those with high blood pressure and could lead to more effective treatment strategies.

SourceUniversity of California - Los Angeles Health Sciences·JournalInternational Journal of Epidemiology·TypeData/statistical analysis·DateApr 14, 2023

Prior treatments influence immunotherapy response in advanced melanoma

A study published in Cancer Cell found that prior treatments, such as CTLA-4 blockade, modify the response to anti-PD-1 checkpoint blockade therapy. The research analyzed data from over 500 patients and identified key factors associated with treatment response. This finding may help scientists create more precise future treatments.

SourceUniversity of California - Los Angeles Health Sciences·JournalCancer Cell·TypeExperimental study·DateApr 10, 2023

Men and women have different obesity drivers, pointing to the need for tailored interventions

A new UCLA study identifies sex-specific brain signatures associated with obesity in men and women, revealing differences in brain networks related to early life adversity, mental health, and sensory stimulation. The findings suggest the need for tailored interventions based on an individual's sex.

SourceUniversity of California - Los Angeles Health Sciences·JournalBrain Communications·TypeExperimental study·DateApr 6, 2023

Early study shows cones in retinal degeneration, thought to be dormant, may retain visual function

Researchers discovered that 'dormant' cone photoreceptors in retinal degeneration continue to produce responses to light and drive retinal activity for vision. The study found that while cones have reduced sensitivity, ganglion cells retain their ability to respond to visual stimuli with similar spatial and temporal sensitivity.

A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapy

A recent study found that the mitochondrial antioxidant MitoQ can reverse the detrimental effects of HIV and antiretroviral therapy on organs such as the brain, heart, and liver. The researchers used humanized mice infected with HIV and treated them with MitoQ for three months.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe Journal of Infectious Diseases·TypeRandomized controlled/clinical trial·DateMar 24, 2023

UCLA-led study uses base editing to correct mutation that causes rare immune deficiency

Researchers at UCLA successfully used base editing to correct a mutation causing rare immune deficiency CD3 delta SCID. The treatment corrected an average of 71% of patient stem cells and allowed them to produce fully functional T cells, suggesting long-term persistence of corrected blood stem cells.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell·TypeExperimental study·DateMar 20, 2023

An extra X chromosome-linked gene may explain decreased viral infection severity in females

A study published in Nature Immunology found that female mouse and human NK cells have more of a specific epigenetic regulator called UTX, which boosts anti-viral function while repressing NK cell numbers. This suggests that therapies need to be tailored to individual differences, including sex.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Immunology·TypeExperimental study·DateMar 16, 2023

New details on how immune cells ‘see’ and respond to mutations in cancer cells may lead to more targeted and effective immunotherapy

A new study has identified the steps by which immune cells recognize and respond to cancer cell mutations, providing insights into why some treatments work for certain patients but not others. Researchers believe their findings will lead to better, more personalized immunotherapies for patients whose immune systems currently do not app...

SourceUniversity of California - Los Angeles Health Sciences·JournalNature·TypeExperimental study·DateMar 8, 2023

Older Black men are likelier to die after surgery than others, particularly following elective procedures, new UCLA research suggests

Researchers found that Black men have a higher mortality rate after surgery compared to other groups, with a 50% higher risk of death after elective procedures. The study suggests that structural racism, poor pre-operative care, and exposure to toxins may contribute to these disparities.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe BMJ·TypeData/statistical analysis·DateMar 1, 2023

Immunotherapy before surgery significantly improves outcomes of patients with melanoma

Researchers found that adding immunotherapy before surgical removal of stage III-IV melanoma significantly improved event-free survival compared to standard-of-care treatment. The study showed that neoadjuvant therapy is superior to the same therapy given in the adjuvant setting.

SourceUniversity of California - Los Angeles Health Sciences·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 1, 2023

Breast cancer risk models may incorrectly classify many women

A recent study found that breast cancer risk models can lead to vastly different recommendations for individual women, depending on the model used and threshold applied. The study highlighted the importance of considering both sensitivity and inaccurate classification when using these models.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of General Internal Medicine·TypeObservational study·DateFeb 14, 2023

Tobacco and e-cigs may put healthy young people at risk of severe COVID illness, new UCLA research suggests

New UCLA research finds that tobacco smoking and vaping can predispose healthy young people to increased inflammation and severe COVID-19. The study, published in Journal of Molecular Medicine, found higher levels of key proteins in plasma from smokers and vapers compared to non-smokers.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Molecular Medicine·TypeExperimental study·DateFeb 9, 2023

Financial coaching for parents in clinic leads to higher attendance at well-child health care visits for their young children

A new study found that financial coaching for parents of infants in a pediatric primary care setting reduced missed well-child care visit rates by half and improved vaccination receipt. The intervention, which connected parents to public benefits and cost-saving services, also increased monthly household income.

UCLA researchers identify possible approach to prevent cancer from evolving to resist treatment

A new study by UCLA Jonsson Comprehensive Cancer Center identifies the DNA roots of resistance to targeted cancer therapy. The researchers found that a protein called DNA-PK plays a crucial role in the process of chromothripsis, which can lead to gene amplification and therapy resistance.

SourceUniversity of California - Los Angeles Health Sciences·JournalCancer Discovery·TypeExperimental study·DateJan 26, 2023

A 4-drug chemotherapy regimen improves survival in stage 4 pancreas cancer

A Phase 3 clinical trial has shown that a four-drug chemotherapy regimen significantly increases overall survival and progression-free survival in patients with stage 4 pancreatic ductal adenocarcinoma. The study's results suggest that this more aggressive treatment approach may be considered for eligible patients.

SourceUniversity of California - Los Angeles Health Sciences·TypeRandomized controlled/clinical trial·DateJan 20, 2023

Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production

Research reveals that commonly used antiretroviral drugs TAF and TDF directly impact mitochondria's energy production in immune cells. The study suggests a larger energy reduction when combined with other antiretrovirals, sparking concerns about potential long-term effects on human cells.

SourceUniversity of California - Los Angeles Health Sciences·JournalMetabolism·TypeExperimental study·DateJan 18, 2023

MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localized prostate cancer

A new study found that MRI-guided radiotherapy is more effective than CT-guided therapy in reducing side effects and improving quality of life for patients with localized prostate cancer. The trial involved 154 patients, who experienced fewer toxicities and better outcomes when treated with MRI guidance.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Oncology·TypeRandomized controlled/clinical trial·DateJan 12, 2023

UCLA Health tip sheet: Masks prevent more than COVID; Obesity and stroke; Reducing low value treatments in Alzheimer’s Disease

Researchers at UCLA Health have found that masks can prevent not only COVID-19 but also whooping cough, while obesity is linked to an increased risk of stroke and cognitive impairment. The institute has also designed a clinical trial to reduce the use of low-value treatments for Alzheimer's disease.

SourceUniversity of California - Los Angeles Health Sciences·JournalAmerican Journal of Infection Control·TypeObservational study·DateDec 21, 2022

The AVID college prep program leads to lower substance use, better health behaviors among high school students, UCLA-led research suggests

The AVID college preparatory program has been shown to have a positive effect on students' social networks, psycho-social outcomes, and health behaviors. Students who participated in the program had lower odds of using substances and associating with substance-using peers compared to those in usual school programs.

SourceUniversity of California - Los Angeles Health Sciences·JournalPEDIATRICS·TypeRandomized controlled/clinical trial·DateDec 16, 2022

Updated findings on a new approach to ER-positive/HER2-negative breast cancer

The phase 1 and phase 2 studies showed that ARV-471 was well-tolerated and could promote substantial estrogen receptor degradation in patients with advanced disease. The study has led to a randomized phase 3 trial comparing ARV-471 with a SERD in patients with ER-positive/HER2-negative advanced breast cancer.

SourceUniversity of California - Los Angeles Health Sciences·TypeRandomized controlled/clinical trial·DateDec 7, 2022

Long COVID patients and those with other illnesses experience similar, negative lingering effects during the pandemic

Research suggests that long COVID patients share similar lingering negative effects on physical, mental, and social well-being with individuals who have other illnesses. The study found moderate-to-severe residual symptoms in 40% of COVID-positive participants and 54% of those who tested negative.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateDec 1, 2022

News tips from UCLA Health: New hope for deadly brain cancer; Mating patterns vs genetics; Do housing interventions improve health? Air pollution and neurodegenerative disease

Researchers at UCLA Health have made significant breakthroughs in understanding deadly brain cancer and the role of housing interventions. A study found a cancer vaccine to be highly effective in treating glioblastoma multiforme, a nearly lethal brain cancer. Additionally, a survey highlighted the need for increased diversity in gastro...

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Oncology·TypeExperimental study·DateDec 1, 2022

Weak evidence that interventions to boost housing affordability and stability promote better health

Research on interventions to mitigate housing insecurity found low-certainty evidence of positive health outcomes, primarily for emergency rent assistance and homeownership assistance. However, existing interventions may need to be paired with other efforts to address structural determinants of health.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeMeta-analysis·DateNov 16, 2022

UCLA researchers offer roadmap for identifying new neuroprotective treatments by leveraging sex differences

Researchers from UCLA have developed a strategy to identify novel treatments for cognitive decline and neurodegenerative diseases by exploiting sex differences in the brain. The study provides a roadmap for disentangling the contribution of sex-specific factors, which can yield treatments optimized for each sex.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Experimental Medicine·DateNov 4, 2022

Brain changes in autism are far more sweeping than previously known, UCLA-led study finds

A new UCLA-led study found comprehensive brain-wide changes in individuals with autism spectrum disorder, refining scientists' understanding of how the condition progresses. The study analyzed gene expression across 11 cortical regions, revealing strong evidence that RNA changes in the brain are likely the cause of ASD.

New onset chronic kidney disease in people with diabetes highest among ethnic, racial minorities

A study published in the New England Journal of Medicine found that new onset CKD rates are higher among Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations compared to white persons with diabetes. The rate declined from 8% in 2015-2016 to 6.4% in 2019-2020.

SourceUniversity of California - Los Angeles Health Sciences·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateOct 31, 2022

UCLA researchers identify model for studying treatments targeting MS progression

Researchers at UCLA have identified an animal model that shares similarities with progressive multiple sclerosis, enabling studies of disability-improving treatments. The model reveals neurodegeneration features and effects on various parts of the brain and spinal cord, holding promise for future treatment discovery.

SourceUniversity of California - Los Angeles Health Sciences·JournalFrontiers in Molecular Neuroscience·DateOct 25, 2022

Telehealth follow-up associated with increased returns and hospitalizations after emergency department visit

Research from UCLA Health Sciences found that telehealth consultations following an emergency department visit were associated with 28 more repeat ED encounters and nearly 11 more return hospital admissions per 1000 patients. The findings highlight the need for careful consideration of when to use telemedicine for post-ED follow-ups.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeData/statistical analysis·DateOct 25, 2022

New analysis led by UCLA Jonsson Comprehensive Cancer Center finds timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer

A new analysis by UCLA Jonsson Comprehensive Cancer Center found that men with prostate cancer benefit from adding androgen deprivation therapy to radiation treatment. The study showed improved metastasis-free survival for patients receiving short-term ADT before or after radiation, especially in those receiving prostate-only RT.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Clinical Oncology·TypeMeta-analysis·DateOct 21, 2022

UCLA researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

Researchers at UCLA Jonsson Comprehensive Cancer Center and Semel Institute identified the gene P300 as a potential therapeutic target for treatment-resistant brain cancer glioblastoma multiforme. By blocking P300, tumor cells can be prevented from recovering and growing under the hostile conditions created by radiation therapy.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Communications·TypeExperimental study·DateOct 19, 2022

Low-income charter school graduates had lower rates of problematic substance use as young adults, UCLA research suggests

A new study from UCLA found that students who attended high-performing charter schools had a 50% lower rate of alcohol use disorder compared to waitlisted students. Males in the intervention group also reported better physical health and lower obesity rates, while females did not show similar benefits.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateOct 6, 2022

Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

A long-term study of over 300 breast cancer survivors found a link between chronic inflammation and cognitive problems. Higher levels of CRP were related to lower reported cognitive function, suggesting that this common test for inflammation may also indicate risk for cognitive concerns.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Clinical Oncology·TypeObservational study·DateSep 30, 2022

Research led by UCLA’s Jonsson Comprehensive Cancer Center tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a novel, cost-effective approach to detect cancer at its early stages using cell-free DNA in blood samples. Their method, cfMethyl-seq, has shown high accuracy and potential for accurate early diagnosis of certain cancers from a single blood test.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Communications·TypeExperimental study·DateSep 29, 2022

Gut bacteria may contribute to susceptibility to HIV infection, UCLA-led research suggests

Researchers found pre-existing differences in gut bacteria between people with and without HIV, including decreased Bacteroides species and increased Megasphaera elsdenii. These changes were present even before infection occurred, suggesting a potential link between gut microbiome and HIV susceptibility.

SourceUniversity of California - Los Angeles Health Sciences·JournalEBioMedicine·TypeRandomized controlled/clinical trial·DateSep 29, 2022